The Mark Foundation–Chordoma Foundation TBXT and Beyond ASPIRE Awards offer up to $500,000 over two years for research developing new ways to target chordoma.
The call focuses on TBXT-derived peptides displayed on cancer cells and other tumour-specific surface targets. It supports basic, translational and preclinical proof-of-concept research.
Eligibility and Project Requirements
- Applicants must work at a nonprofit academic or research institution.
- Applications are accepted worldwide.
- Principal investigators must be independent researchers.
- Each researcher may submit one application as PI.
- Participation as a co-investigator on other proposals is unrestricted.
- Clinical trials and late-stage therapeutic development are excluded.
Funding Details
- Maximum: $500,000.
- Duration: Up to 24 months.
- The total includes indirect costs, capped at 10% of direct costs.
- Revenue-sharing terms apply.
Deadline
- Concept letter: December 10, 2026, at 5 p.m. ET.
Invitations: End of January 2027.
Full application: March 1, 2027.
Grant start: June 1, 2027.